Kuno Sommer, Ph.D. is the Vice-Chairman of the Board of Directors. Dr. Sommer (University of Basel), joined F. Hoffmann-La Roche Ltd in 1986 and worked in various functions at Roche until 1999, spending 4 years in the US. In his last position at Roche he became a member of the Executive Committee, responsible for the Flavours and Fragrances division (today Givaudan Ltd). From 2000 until 2006 he was appointed CEO of Berna Biotech Ltd, a listed global vaccine company, which was sold to Crucell N.V. in 2006 (today Johnson&Johnson). In his last operational role Dr. Kuno Sommer headed the contract research division of Harlan Laboratories Ltd, a leading player in this field. Today he focuses on active board memberships in the Life Science sector. In addition to various directorships with startup companies, beginning April 2012 he became the Chairman of the Bachem group.